论文部分内容阅读
目的:探讨我院妇科门诊中成药的使用情况,为临床用药以及中成药的研发、生产、销售等提供参考。方法:调取我院2011-2013年的妇科门诊处方,分别统计所用中成药的名称、剂型、销售金额以及DDDs等。结果:2011-2013年妇科门诊处方中,含中成药的处方比例(58.80%~62.64%)以及处方中中药品种数(1.24~1.61种)增加明显。妇科中成药年销售总额增长迅速(分别为45.49%,9.65%),剂型以胶囊、片剂以及颗粒剂三种口服剂型用药频率最高。三年中DDDs排名前三位的药物有变化,但均以清热剂、理血剂为主。结论:我院妇科门诊中成药使用率较高,中成药处方数、年销售额以及单张处方中中成药品种数均呈增加趋势。
OBJECTIVE: To explore the use of proprietary Chinese medicines in gynecology outpatient clinics in our hospital and to provide references for the clinical research, development, production and sales of proprietary Chinese medicines. Methods: To retrieve the prescription of gynecology outpatients in our hospital from 2011 to 2013, and to make statistics on the name, dosage form, sales amount and DDDs of the proprietary Chinese medicines used. Results: The proportion of prescriptions containing proprietary Chinese medicines (58.80% -62.64%) and the number of traditional Chinese medicines (1.24-1.61) in prescriptions in gynecology outpatient clinics in 2011-2013 increased significantly. The total annual sales of gynecological proprietary Chinese medicines increased rapidly (45.49% and 9.65% respectively). The three dosage forms of capsules, tablets and granules took the highest dosage. DDDs in the past three years, the top three drugs have changed, but all with heat-clearing agents, blood-based agent. Conclusion: The utilization rate of proprietary Chinese medicines in gynecology clinics in our hospital is high. The number of prescriptions of Chinese patent medicines, the annual sales volume and the varieties of proprietary Chinese medicines in single prescriptions all show an increasing trend.